These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17043342)

  • 1. Narrative review: reperfusion strategies for ST-segment elevation myocardial infarction.
    Ting HH; Yang EH; Rihal CS
    Ann Intern Med; 2006 Oct; 145(8):610-7. PubMed ID: 17043342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reperfusion strategies for ST-elevation myocardial infarction.
    Shah SR; Hochberg CP; Pinto DS; Gibson CM
    Curr Cardiol Rep; 2007 Jul; 9(4):281-8. PubMed ID: 17601394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines.
    Spinler SA; Hilleman DE; Cheng JW; Howard PA; Mauro VF; Lopez LM; Munger MA; Gardner SF; Nappi JM
    Ann Pharmacother; 2001 May; 35(5):589-617. PubMed ID: 11346067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study.
    Armstrong PW;
    Eur Heart J; 2006 Jul; 27(13):1530-8. PubMed ID: 16757491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Strategic Reperfusion Early After Myocardial Infarction (STREAM) study.
    Armstrong PW; Gershlick A; Goldstein P; Wilcox R; Danays T; Bluhmki E; Van de Werf F;
    Am Heart J; 2010 Jul; 160(1):30-35.e1. PubMed ID: 20598969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ST-segment recovery and prognosis in patients with ST-elevation myocardial infarction reperfused by prehospital combination fibrinolysis, prehospital initiated facilitated percutaneous coronary intervention, or primary percutaneous coronary intervention.
    Thiele H; Scholz M; Engelmann L; Storch WH; Hartmann A; Dimmel G; Pfeiffer D; Schuler G;
    Am J Cardiol; 2006 Nov; 98(9):1132-9. PubMed ID: 17056313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of a pharmaco-invasive reperfusion strategy in rural ST-elevation myocardial infarction patients with expected delays due to long-distance transfers.
    Larson DM; Duval S; Sharkey SW; Garberich RF; Madison JD; Stokman PJ; Dirks TG; Westin RK; Harris JL; Henry TD
    Eur Heart J; 2012 May; 33(10):1232-40. PubMed ID: 22041553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ST-segment resolution and prognosis after facilitated versus primary percutaneous coronary intervention in acute myocardial infarction: a meta-analysis.
    Eitel I; Franke A; Schuler G; Thiele H
    Clin Res Cardiol; 2010 Jan; 99(1):1-11. PubMed ID: 19727894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current perspectives on reperfusion therapy for acute ST-segment elevation myocardial infarction: integrating pharmacologic and mechanical reperfusion strategies.
    Waters RE; Mahaffey KW; Granger CB; Roe MT
    Am Heart J; 2003 Dec; 146(6):958-68. PubMed ID: 14660986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).
    Bromberg-Marin G; Marin-Neto JA; Parsons LS; Canto JG; Rogers WJ;
    Am J Cardiol; 2006 Nov; 98(9):1125-31. PubMed ID: 17056312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between therapeutic time intervals and intermediate term left ventricular systolic function in patients treated with facilitated percutaneous coronary intervention for acute myocardial infarction.
    Meyborg P; Abdel-Wahab M; Herrmann G; Geist V; Khattab AA; Krüger D; Lins M; Toelg R; Simon R; Richardt G
    Clin Res Cardiol; 2007 Feb; 96(2):94-102. PubMed ID: 17160565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reperfusion strategies in ST-segment elevation myocardial infarction.
    Stiermaier T; Desch S; Schuler G; Thiele H; Eitel I
    Minerva Med; 2013 Aug; 104(4):391-411. PubMed ID: 24008602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both?
    Silva MA; Donovan JL; Gandhi PJ; Volturo GA
    Vasc Health Risk Manag; 2006; 2(1):39-48. PubMed ID: 17319468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of upstream antiplatelet therapy use before primary percutaneous coronary intervention for acute ST-elevation myocardial infarction (from the CRUSADE National Quality Improvement Initiative).
    Alexander D; Mann N; Ou FS; Peterson ED; Ohman EM; Gibler WB; Roe MT
    Am J Cardiol; 2008 Nov; 102(10):1335-40. PubMed ID: 18993151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Present and potential future paradigms for the treatment of ST-segment elevation acute myocardial infarction.
    Chew DP; Moliterno DJ; Herrmann HC
    J Invasive Cardiol; 2002 Feb; 14 Suppl A():3A-20A. PubMed ID: 11847402
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of ST-elevation myocardial infarction: an update on pharmacoinvasive recanalization.
    Kashani A; Giugliano RP
    Am J Cardiovasc Drugs; 2008; 8(3):187-97. PubMed ID: 18533739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing acute coronary syndrome: evidence-based approaches.
    Spinler SA
    Am J Health Syst Pharm; 2007 Jun; 64(11 Suppl 7):S14-24. PubMed ID: 17519441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials.
    Ndrepepa G; Neumann FJ; Deliargyris EN; Mehran R; Mehilli J; Ferenc M; Schulz S; Schömig A; Kastrati A; Stone GW
    Circ Cardiovasc Interv; 2012 Oct; 5(5):705-12. PubMed ID: 23048052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).
    Koeth O; Zahn R; Gitt AK; Bauer T; Juenger C; Senges J; Zeymer U;
    Am J Cardiol; 2009 Oct; 104(8):1074-7. PubMed ID: 19801027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.
    Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Claeys MJ; Cools F; Hill KA; Skene AM; McCabe CH; Braunwald E;
    N Engl J Med; 2005 Mar; 352(12):1179-89. PubMed ID: 15758000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.